Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 40,08€(+1.092,86%). Der Median liegt bei 44,92€(+1.236,90%).
Kaufen | 9 |
Halten | 0 |
Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Trulieve Announces Registration Statement Filing
TALLAHASSEE, Fla. , June 30, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced that it filed a shelf registration statement on Form S-3 (the Registration Statement) with the United States Securities and Exchange Commission ("SEC") on June 30, 2025 to register a base shelf prospectus.» Mehr auf prnewswire.com
Marijuana Market Watch: Stocks to Track as the Industry Expands in 2025
The U.S. cannabis industry continues to expand as legalization momentum builds. In 2025, total market revenue is projected to exceed $45 billion. Additionally, over two-thirds of Americans now live in a state where cannabis is legal. Many operators are scaling rapidly to meet this demand. Meanwhile, new legislation could further loosen restrictions at the federal level. These shifts present unique opportunities for investors focused on growth sectors. However, volatility remains high. Therefore, traders must approach cannabis stocks with discipline. Technical analysis plays a vital role here. Watching for volume spikes, trend confirmations, and breakout patterns can help pinpoint setups. Still, no setup is complete without a risk plan. Stop-loss levels should be pre-determined. Proper position sizing is also key. These tools allow traders to control downside while remaining flexible. As we begin the week, several top marijuana stocks appear promising based on their chart setups and recent price behavior.» Mehr auf marijuanastocks.com
Marijuana Stocks to Watch: Navigating Volatility With Smart Risk and Timing
The U.S. cannabis industry continues to expand, presenting opportunities for savvy investors. Legal marijuana sales reached $30 billion in 2024 and are expected to grow steadily through 2025. Forecasts suggest the total market could top $34 billion this year alone. Additionally, over 40 states now permit medical use, while more than 20 allow recreational sales. These developments help fuel investor interest in top-performing cannabis stocks. Meanwhile, pending legislation in Congress could act as a catalyst. Traders should pay close attention to volume spikes and support zones. Technical indicators like moving averages and RSI can help identify strong setups. However, it's crucial to manage risk properly. Set stop-loss levels below key swing lows. Position sizing should reflect overall portfolio risk. While the potential upside is appealing, discipline is vital. With the right strategy, cannabis stocks can offer both short-term trades and long-term gains.» Mehr auf marijuanastocks.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 275,24 Mio | 0,19% |
Bruttoeinkommen | 169,36 Mio | 5,17% |
Nettoeinkommen | −30,38 Mio | 42,08% |
EBITDA | 30,16 Mio | 64,01% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 626,13 Mio€ |
Anzahl Aktien | 191,08 Mio |
52 Wochen-Hoch/Tief | 11,70€ - 2,56€ |
Dividenden | Nein |
Beta | 1,48 |
KGV (PE Ratio) | −4,53 |
KGWV (PEG Ratio) | −0,05 |
KBV (PB Ratio) | 0,61 |
KUV (PS Ratio) | 0,64 |
Unternehmensprofil
Trulieve Cannabis Corp. ist zusammen mit ihren Tochtergesellschaften als medizinisches Cannabisunternehmen tätig. Es baut an und produziert Produkte im eigenen Haus und vertreibt seine Produkte an Trulieve-Markengeschäfte (Dispensaries) in Florida sowie durch Hauszustellung. Das Unternehmen stellt unter den Marken Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli und Roll One Blüten, Esswaren, Verdampferkartuschen, Konzentrate, Topicals, Kapseln, Tinkturen, auflösbare Pulver und Nasensprays her. Mit Stand vom 16. März 2022 betrieb das Unternehmen 162 Apotheken, darunter 113 Apotheken in Florida, 19 angeschlossene Apotheken in Pennsylvania, 17 Apotheken in Arizona, fünf Apotheken in Kalifornien, drei Apotheken in Maryland, zwei Apotheken in Massachusetts, zwei Apotheken in West Virginia und eine Apotheke in Connecticut. Trulieve Cannabis Corp. betrieb auch Anbau- und Verarbeitungsanlagen in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania und West Virginia. Das Unternehmen war früher unter dem Namen Schyan Exploration Inc. / Exploration Schyan Inc. bekannt und änderte im September 2018 seinen Namen in Trulieve Cannabis Corp. um. Trulieve Cannabis Corp. wurde 1940 gegründet und hat seinen Hauptsitz in Quincy, Florida.
Name | TRULIEVE CANNABIS |
CEO | Kimberly Rivers |
Sitz | Quincy, fl USA |
Website | |
Industrie | Körperpflegeprodukte |
Börsengang | |
Mitarbeiter | 6.000 |
Ticker Symbole
Börse | Symbol |
---|---|
Cnq | TRUL.CN |
Pnk | TCNNF |
Frankfurt | T0A.F |
Düsseldorf | T0A.DU |
München | T0A.MU |
Assets entdecken
Shareholder von TRULIEVE CANNABIS investieren auch in folgende Assets